Feasibility Of Pd-L1 Expression Testing In Non-Small Cell Lung Cancer From Pleural And Pericardial Effusion Samples

被引：0
|
作者：
Kim, J. S. [1 ]
Heymann, J. J. [1 ]
Pagan, C. [1 ]
Crapanzano, J. P. [1 ]
Fazlollahi, L. [1 ]
Haghighi, M. [1 ]
Stoopler, M. B. [1 ]
Sonett, J. R. [1 ]
Sacher, A. G. [1 ]
Shu, C. A. [1 ]
Rizvi, N. A. [1 ]
Bulman, W. A. [1 ]
Saqi, A. [1 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2017年 / 195卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2886
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Effect of neoadjuvant chemoimmunotherapy on PD-L1 expression in non-small cell lung cancer
    Stoykova, S.
    Chriqui, L.
    Berchtold, E. Abdelnour
    Peters, S.
    Perentes, J. Y.
    Berezowska, S.
    VIRCHOWS ARCHIV, 2024, 485 : S20 - S20
  • [32] TMB, genetic alterations and PD-L1 expression in non-small cell lung cancer
    Gureviciene, Giedre
    Matulione, Jurgita
    Poskiene, Lina
    Miliauskas, Skaidrius
    Zemaitis, Marius
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [33] PD-L1 expression for advanced non-small cell lung cancer patients with cancer cachexia
    Morimoto, Kenji
    Yamada, Tadaaki
    CANCER SCIENCE, 2023, 114 : 1410 - 1410
  • [34] PD-L1 determination in cytological and histological samples in patients with non-small cell lung cancer
    Baeza Mena, Sonia Margarita
    Centeno Clemente, Carmen Angela
    Andreo Garcia, Felipe
    Serra Mitja, Pere
    Tazi Mezalek, Rachid
    Mate Sanz, Jose Luis
    Martinez Barenys, Carlos
    Carcereny Costa, Enric
    Margeli Cervera, Victor
    Abad Capa, Jorge
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [35] Spatial heterogeneity of PD-L1 expression and the risk for misclassification of PD-L1 immunohistochemistry in non-small cell lung cancer
    Dori, Shani Ben
    Aizic, Asaf
    Sabo, Edmond
    Hershkovitz, Dov
    LUNG CANCER, 2020, 147 : 91 - 98
  • [36] Regulation of PD-L1 expression in non-small cell lung cancer by interleukin-1β
    Hirayama, Aiko
    Tanaka, Kentaro
    Tsutsumi, Hirono
    Nakanishi, Takayuki
    Yamashita, Sho
    Mizusaki, Shun
    Ishii, Yumiko
    Ota, Keiichi
    Yoneshima, Yasuto
    Iwama, Eiji
    Okamoto, Isamu
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [37] Feasibility and reliability of evaluate PD-L1 expression determination using small biopsy specimens in non-small cell lung cancer
    Chen, Minjiang
    Xu, Yan
    Zhao, Jing
    Li, Ji
    Liu, Xiangning
    Zhong, Wei
    Wang, Mengzhao
    THORACIC CANCER, 2021, 12 (17) : 2339 - 2344
  • [38] PD-L1 Expression in Non-Small Cell Lung Cancer: Data from a Referral Center in Spain
    Saez de Gordoa, Karmele
    Lopez, Ingrid
    Marginet, Marta
    Coloma, Berta
    Frigola, Gerard
    Vega, Naiara
    Martinez, Daniel
    Teixido, Cristina
    DIAGNOSTICS, 2021, 11 (08)
  • [39] Clinical Significance of PD-L1 Expression in Brain Metastases from Non-small Cell Lung Cancer
    Takamori, Shinkichi
    Toyokawa, Gouji
    Okamoto, Isamu
    Takada, Kazuki
    Kinoshita, Fumihiko
    Kozuma, Yuka
    Matsubara, Taichi
    Haratake, Naoki
    Akamine, Takaki
    Mukae, Nobutaka
    Hirai, Fumihiko
    Tagawa, Tetsuzo
    Oda, Yoshinao
    Iwaki, Toru
    Iihara, Koji
    Nakanishi, Yoichi
    Maehara, Yoshihiko
    ANTICANCER RESEARCH, 2018, 38 (01) : 553 - 557
  • [40] Sensitivity of a PD-L1-Analysis in Patients with non-small cell Lung Cancer (NSCLC) with Pleural Effusion
    Hagmeyer, L.
    Treml, M.
    Richter, K.
    Hekmat, K.
    Heldwein, M.
    Schaefer, S.
    Buettner, R.
    Randerath, W. J.
    PNEUMOLOGIE, 2020, 74 : S40 - S41
12345